Immunological mechanisms in the pathogenesis of diabetic retinopathy
- PMID: 18340447
- DOI: 10.1007/s00281-008-0111-x
Immunological mechanisms in the pathogenesis of diabetic retinopathy
Abstract
There is an accumulating body of evidence that immunological mechanisms play a prominent role in the pathogenesis of diabetic retinopathy (DR), which is characterized by many features typical of inflammation. The upregulation of cytokines and other inflammatory mediators leading to persistent low-grade inflammation and an influx of leukocytes, is believed to contribute actively to DR-associated damage to the retinal vasculature and retinal neovascularization. This review will describe preclinical and clinical studies that document an inflammatory basis for DR and that support the use of nonsteroidal anti-inflammatory drugs, corticosteroids, and anti-vascular endothelial growth factor agents in its treatment. In addition, emerging therapeutic approaches based on ongoing investigations will be discussed, including those involving blockade of angiotensin receptors and other molecular targets such as tumor necrosis factor-alpha.
Similar articles
-
Diabetic Retinopathy: Vascular and Inflammatory Disease.J Diabetes Res. 2015;2015:582060. doi: 10.1155/2015/582060. Epub 2015 Jun 7. J Diabetes Res. 2015. PMID: 26137497 Free PMC article. Review.
-
The role of inflammation in diabetic eye disease.Semin Immunopathol. 2019 Jul;41(4):427-445. doi: 10.1007/s00281-019-00750-7. Epub 2019 Jun 7. Semin Immunopathol. 2019. PMID: 31175392 Review.
-
Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.Curr Opin Investig Drugs. 2010 May;11(5):507-14. Curr Opin Investig Drugs. 2010. PMID: 20419596 Review.
-
Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy.Int J Biochem Cell Biol. 2009 Dec;41(12):2368-71. doi: 10.1016/j.biocel.2009.07.011. Epub 2009 Jul 29. Int J Biochem Cell Biol. 2009. PMID: 19646547 Review.
-
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.J Diabetes Res. 2016;2016:2156273. doi: 10.1155/2016/2156273. Epub 2016 Sep 28. J Diabetes Res. 2016. PMID: 27761468 Free PMC article. Review.
Cited by
-
Autoimmune-Mediated Retinopathy in CXCR5-Deficient Mice as the Result of Age-Related Macular Degeneration Associated Proteins Accumulation.Front Immunol. 2019 Aug 14;10:1903. doi: 10.3389/fimmu.2019.01903. eCollection 2019. Front Immunol. 2019. PMID: 31474986 Free PMC article.
-
Plasma kallikrein and diabetic macular edema.Curr Diab Rep. 2010 Aug;10(4):270-5. doi: 10.1007/s11892-010-0127-1. Curr Diab Rep. 2010. PMID: 20535647
-
Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.Int J Mol Sci. 2014 Jan 22;15(1):1606-24. doi: 10.3390/ijms15011606. Int J Mol Sci. 2014. PMID: 24451141 Free PMC article.
-
Diabetic retinopathy: targeting vasoregression.Diabetes. 2011 Jan;60(1):9-16. doi: 10.2337/db10-0454. Diabetes. 2011. PMID: 21193734 Free PMC article. Review. No abstract available.
-
Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy.Int J Mol Sci. 2018 Apr 2;19(4):1056. doi: 10.3390/ijms19041056. Int J Mol Sci. 2018. PMID: 29614818 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical